Key result
Glycemic abnormalities accelerate high-risk nontarget coronary lesion progression and increase recurrent cardiovascular events.
Why the study?
Untreated nontarget lesions account for over 50% of recurrent cardiovascular events, with disease progression and adverse outcomes exacerbated in patients with diabetes and early glucose metabolism abnormalities.
Answers are grounded in this paper and cite their sources.
Acute glucose fluctuations and poor glycemic control significantly drive the rapid progression of untreated nontarget coronary lesions, highlighting the need for comprehensive metabolic management and precise risk stratification beyond target lesion intervention.
The introduction of drug-eluting stents has significantly reduced the incidence of in-stent restenosis. Despite this, recurrent cardiovascular events related to untreated nontarget lesions (NTLs) are becoming more common and accounting for more than 50% of all recurrent cardiovascular events. In patients with diabetes, factors such as prolonged disease duration, poor glycemic control, insulin use, and inadequate lipid management may exacerbate the progression of NTLs and adverse cardiovascular events. Additionally, glycemic fluctuations have been linked to an increased risk of future cardiovascular events in patients with early glucose metabolism abnormalities and acute hyperglycemia. In this review, we explored the clinical and plaque characteristics of patients with diabetes and early glucose metabolism disorders, the percutaneous coronary intervention strategies for NTLs, and their prognostic implications. Furthermore, we investigated the mechanistic links between adverse cardiovascular outcomes and elevated inflammation, oxidative stress, hypercoagulability, and endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a review in Nontarget coronary lesions in patients with diabetes and early abnormal glucose metabolism. Diabetes, early glucose metabolism abnormalities, and glycemic fluctuations vs. Normal glucose metabolism was evaluated. Poor glycemic control, early glucose metabolism abnormalities, and acute glycemic fluctuations exacerbate the progression of high-risk nontarget coronary lesions and increase recurrent cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: